Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment.
NCT ID: NCT00337831
Last Updated: 2011-06-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2006-05-31
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Performance of predilution hemofiltration, predilution hemodiafiltration or postdilution hemodiafiltration
Performance of predilution hemofiltration, predilution hemodiafiltration or postdilution hemodiafiltration is followed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* of which presently on high-flux HD \>= 1 month
* 18 years \< age \< 85 years
* blood flow rate \>= 300ml/min
Exclusion Criteria
* expected transplant within \< 1 year
* infectious diseases
* pregnancy
* chronic inflammation condition
* treated with single needle dialysis
* presently treated with hemodiafiltration or low-flux hemodiafiltration
* expected intradialytic body weight gain \>= 4kg
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gambro Corporate Research, Sweden
OTHER
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital Ghent
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raymond Vanholder, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Ghent
Ghent, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Website University Hospital Ghent
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006/127
Identifier Type: -
Identifier Source: org_study_id